Cambridge researchers to hold free public meeting on dementia


Scientists based in Cambridge are holding a free public meeting about dementia on 10 September 2014.

The meeting will take place at the Babraham Institute’s Conference Centre at the Babraham Research Campus and has been organised by researchers in the Alzheimer’s Research UK Cambridge Network. This event is a great opportunity to hear Cambridge-based scientists and clinicians discuss their work.

The event is free but booking is essential in order to access the campus. Transport arrangements can be made if requested. Please book at or by contacting Claire Harwell on or call on 01223 496401.

Alzheimer’s Research UK is the UK’s leading dementia research charity and has funded over £6 million worth of research projects in Cambridge. This funding gives researchers the opportunity to investigate the causes of dementia and find ways to help with development of potential treatments.

Speakers will include Dr Stephen Barclay, a clinical senior lecturer based in palliative care at the University of Cambridge’s School of Clinical Medicine who will be discussing end of life care for dementia patients. Also speaking will be Dr Tatyana Dias, a postdoctoral researcher at the Gurdon Institute, who will discuss her research using brain cells grown in the lab. The final talk will be given by Dr Keith Tan, senior director of the pharmaceutical company Medimmune about the best way to translate research findings into suitable treatments for dementia.

Dr Michael Coleman, Alzheimer’s Research UK Cambridge Network Co-ordinator and Research Group Leader at the Babraham Institute, said:

“We are delighted to be organising this important event at the Babraham Research Campus. Alzheimer’s disease and other dementias affect nearly 7,500 people in the Cambridgeshire area and this number is expected to rise. Cambridge has long been established as a world-class hub in dementia research and this is a fantastic opportunity for the public to hear what researchers and clinicians in Cambridge have achieved.”

Dr Simon Ridley, Head of Research at Alzheimer’s Research UK, said:

 “As an estimated 23 million people in the UK have a close family member of friend affected by dementia, it is vital that the public is kept informed about the steps dementia researchers are making towards defeating this devastating condition. As a fundraising charity, we rely on the generosity of the public to fund our research and it’s only right that we show people the progress being made.”

The free meeting runs from 4 – 6.00pm at the Babraham Institute’s Conference Centre, Babraham Research Campus, Cambridge CB22 3AT. Light refreshments will be provided.


For further information, or to speak with a spokesperson from Alzheimer’s Research UK, please call Louise Walker, Science Communications Officer, on 0300 111 5 666, 07500 336132 or email

Notes to editors:

  • Alzheimer’s Research UK is the UK’s leading charity specialising in finding preventions, treatments and a cure for dementia.
  • To help us defeat dementia, donate today by visiting or calling 0300 111 5555.
  • We are currently supporting dementia research projects worth over £22 million in leading Universities across the UK.
  • Find out more about the event and download the flyer on our website:
  • Our Defeat Dementia campaign, a pledge to raise £100 million in five years to grow the research field and accelerate progress towards new treatments and preventions, was announced by the Prime Minister at the G8 legacy event on 19 June 2014. For more information visit
  • The Babraham Institute undertakes international quality life sciences research, generating new knowledge of biological mechanisms underpinning ageing, development and the maintenance of health.
  • The Babraham Institute receives strategic funding from the Biotechnology and Biological Sciences Research Council (a total of £28.8M in 2013-14).   For more information about the Babraham Institute and the BBSRC see:

Alzheimer’s Research UK is the UK’s leading dementia research charity. We fund innovative research with the power to transform lives, campaign for government action, and help people to understand dementia and the progress we’re making with research.

Our people are vital to our mission. Our pioneering spirit is reflected in the energy and drive of our staff – all of whom play a key role in helping realise our vision of a world where people are free from the fear, harm and heartbreak of dementia.

By working at Alzheimer’s Research UK, you will be part of an organisation that has been recognised nationally as an outstanding place to work. In 2020, we were listed 39th in the prestigious Sunday Times 100 Best Not-for-Profit Organisations to Work For. We were also awarded a 2-star accreditation by Best Companies, recognising outstanding levels of workplace engagement and were listed in the 75 Best Companies to Work For in the East of England.

Alzheimer's Research UK